v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 4,963 $ 1,292
Accounts receivable, net 391,064 88,356
Inventories 176,419 207,282
Prepaid expenses and other assets 19,744 21,978
Total current assets 592,190 318,908
Property, plant and equipment, net 967,276 922,868
Operating lease assets 49,976 52,195
Goodwill and other intangible assets, net 23,529 22,048
Other assets 8,228 8,279
Total assets 1,641,199 1,324,298
Current liabilities    
Accounts payable 45,576 61,272
Accrued expenses and other liabilities 105,427 72,879
Accrued warranty 6,611 5,726
Line of credit 443,947 202,600
Total current liabilities 601,561 342,477
Deferred income taxes 56,032 56,032
Operating lease liabilities 39,788 41,979
Non-current accrued warranty 17,180 17,109
Other long-term liabilities 16,559 16,559
Total liabilities 731,120 474,156
Commitments and contingencies
Stockholders' equity    
Preferred stock, $0.01 par value, 3,000,000 shares authorized; none issued and outstanding 0 0
Common stock, $0.01 par value, 360,000,000 shares authorized; 141,170,958 and 141,098,251 shares issued and 107,227,012 and 107,154,305 shares outstanding, at March 31, 2025 and December 31, 2024, respectively 1,412 1,411
Additional paid-in capital 147,655 148,153
Retained earnings 1,622,884 1,562,450
Treasury stock, at cost, 33,943,946 and 33,943,946 shares at March 31, 2025 and December 31, 2024 (861,872) (861,872)
Total stockholders' equity 910,079 850,142
Total liabilities and stockholders' equity $ 1,641,199 $ 1,324,298